Navigation Links
Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
Date:11/3/2008

------------------------------------------

Squamous Cell 3x10(9) 3 Minor response

Carcinoma 26% reduction in

Head and Neck lymph node

-------------------------------------------------------------------------

Unknown 3x10(9) 6 SD

-------------------------------------------------------------------------

Pancreas 3x10(10) 6* SD

-------------------------------------------------------------------------

Prostate 3x10(10) 5* SD

-------------------------------------------------------------------------

Prostate 3x10(10) 5 SD

-------------------------------------------------------------------------

Melanoma 1x10(10) 4 SD

-------------------------------------------------------------------------

Pancreas 3x10(10) 2 SD, but progressed

clinically

-------------------------------------------------------------------------

* patients still on study. CR=complete response,

PR=partial response, SD=stable disease

"These are extraordinary results for a Phase I trial," said Dr. Brad Thompson, President and CEO of Oncolytics. "To see tumour stabilization or better in this patient population is highly unusual."

The trial (REO 010) has two components. The first is an open-label, dose-escalating, non-randomized study of REOLYSIN(R) given intravenously with docetaxel every three weeks. In this portion of the trial, which was completed in August 2008, standard dosages of docetaxel were delivered to patients with escalating dosages of REOLYSIN(R) intravenously. The second component of the trial includes the enrolment of a f
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
2. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
3. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
4. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
5. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
6. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
7. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
8. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
9. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
10. Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/l5jcdk/genotyping_market ) has announced the ... & by Products - Global Forecast to 2020" ... market is expected to reach $17.0 Billion in 2020 ... 22.3% during the forecast period of 2015 to 2020 ... availability of a range of products for wide applications, ...
(Date:6/2/2015)... --  BioClinica ® , Inc., a specialty clinical ... David Peters , an accomplished senior finance and accounting ... Financial Officer (CFO) and will be joining BioClinica on ... 25 years of financial and accounting experience with a ... knowledge in all areas of finance, accounting and business ...
(Date:6/2/2015)... , June 2, 2015  Alere Inc. (NYSE: ... diagnostics, joined the White House Antibiotic Stewardship Forum ... to support and advance the President,s National Action ... include a number of measurable goals and objectives ... will help healthcare providers protect their patients through ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 GenoCAD ... synthesis to improve protein expression, announced the formation of ... six executives and entrepreneurs with a broad range of ... , The team includes: , Jimmy Roussel, Entrepreneur ... Roussel has a background in technology and marketing. He ...
Breaking Biology Technology:Genotyping Market Report 2015 by Technology, Application & by Products - Global Forecast to 2020 for the $17 Billion Market 2BioClinica Names David Peters New Chief Financial Officer 2Alere Announces Broad Initiatives to Help Combat Antibiotic Resistance during White House Antibiotic Stewardship Forum 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3
... Reflects Emphasis on Drug Development and Recent ... Private ... Inc. (Nasdaq: LXRX ) announced several changes to the,composition ... development and the completion of a major strategic financing,with Invus, ...
... N.C., Sept. 25 DrScore.com, a nationwide,service ... their physicians,feedback online, announced today that it ... provides medical practices with free,practice-branded Web sites ... the terms of the partnership between DrScore ...
... Israel, Sept. 25 ,Monsanto Company (NYSE: MON ... collaboration to improve nitrogen use efficiency in corn, ... exclusive rights to,a number of genes discovered by ... of nitrogen. Monsanto will work to evaluate the ...
Cached Biology Technology:Lexicon Appoints Judith Swain, M.D. to Board of Directors 2Lexicon Appoints Judith Swain, M.D. to Board of Directors 3Lexicon Appoints Judith Swain, M.D. to Board of Directors 4DrScore.com Partners With Vivacare For Patient Education And Feedback 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 3
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a ... established helmet producer, announced today that they will expand ... the world,s first bio-sensing cycling helmet and the first ... in two new colors in order to give cyclists ... product. In addition, LifeBEAM and Lazer announced their plan ...
(Date:4/21/2015)... 2015 High crime rate, ... boosting access control systems market in Saudi ... recently published report by TechSci Research " Saudi Arabia Access ... control systems market in Saudi Arabia ... access control systems market in the Kingdom is growing ...
(Date:4/14/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® smart ... Design Awards under the category  ,Product Design – Technology,. ... are part of a global multi-disciplinary awards program. The ... marketplace, industry and judging panel. Winners will be announced ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... Chemists say they have identified a gene that appears to ... diabetes, also known as insulin-dependent or juvenile diabetes, a disease ... is on the rise worldwide. They described their findings, which ... gene therapy, today at the 229th national meeting of the ...
... International HapMap Consortium, boosted by an additional $3.3 million ... even more powerful map of human genetic variation than ... genes related to common diseases, such as asthma, cancer, ... launched in October 2002, the consortium set September 2005 ...
... (MRS) for the first time to examine energy production ... have found substantial energy deficits in failing hearts. , ... the Proceedings of the National Academy of Sciences, confirm ... failure, and suggest new treatments designed to reduce energy ...
Cached Biology News:Towards precise classification of cancers based on robust gene functional expression profiles 2Towards precise classification of cancers based on robust gene functional expression profiles 3International HapMap consortium expands mapping effort 2International HapMap consortium expands mapping effort 3International HapMap consortium expands mapping effort 4Special Imaging Study Shows Failing Hearts Are 'Energy Starved' 2
... analysis of gene expression) technology ... Expression profiles generated by SAGE ... low-abundance transcripts making it possible ... I-SAGE Kit is designed to ...
...
Human PDGF, CF...
... The mycobacteria in Complete Freund's adjuvant attract ... site which enhances the immuneresponse. For this ... for the initial injections; Incomplete Freund's adjuvant ... (preferably in saline) are typically mixed with ...
Biology Products: